All Stories

  1. Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults
  2. The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis
  3. Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease
  4. Expansion of the immature B lymphocyte compartment in Graves' disease
  5. Treating subclinical hypothyroidism in individuals with or without mental health problems –A Delphi based expert consensus study in two countries
  6. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
  7. The GLP‐1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes
  8. Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment
  9. Editorial: Treatment of subclinical thyroid dysfunction in patients with comorbidities
  10. Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature
  11. Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison's disease cohort
  12. Subclinical thyroid dysfunction and incident diabetes: a systematic review and an individual participant data analysis of prospective cohort studies
  13. Efficacy and Safety of Triiodothyronine Treatment in Cardiac Surgery or Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  14. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  15. Publisher Correction: Hypothyroidism
  16. Hypothyroidism
  17. Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations
  18. Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population
  19. Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction
  20. Postradioiodine Graves' management: The PRAGMA study
  21. The prevalence and significance of nonuniform thyroid radio‐isotope uptake in patients with Graves’ disease
  22. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  23. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  24. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis
  25. Does Clinical and Biochemical Thyroid Dysfunction Impact on Endometrial Cancer Survival Outcomes? A Prospective Database Study
  26. A global country‐level analysis of the relationship between obesity and COVID ‐19 cases and mortality
  27. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
  28. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  29. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  30. Iatrogenic hypoglycaemia following glucose‐insulin infusions for the treatment of hyperkalaemia
  31. Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
  32. Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2)
  33. Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study
  34. Obesity: A critical risk factor in the COVID‐19 pandemic
  35. Multinational Survey of Treatment Practices of Clinicians Managing Subclinical Hypothyroidism in Older People in 2019
  36. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction
  37. Thyroid Function and the Risk of Fibrosis of the Liver, Heart, and Lung in Humans: A Systematic Review and Meta-Analysis
  38. Treatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial
  39. Thyroid and Heart
  40. Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study
  41. Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1)
  42. Novel uses of thyroid hormones in cardiovascular conditions
  43. Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction
  44. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
  45. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
  46. Thyroid Hormone Therapy for Subclinical Hypothyroidism
  47. Hypothyroidism in the older population
  48. Trends, Determinants, and Associations of Treated Hypothyroidism in the United Kingdom, 2005–2014
  49. Therapeutic challenges in the application of serum thyroid stimulating hormone testing in the management of patients with hypothyroidism on replacement thyroid hormone therapy: a review
  50. Liothyronine cost and prescriptions in England
  51. Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease
  52. Analysis of BAFF gene polymorphisms in UK Graves’ disease patients
  53. The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data
  54. Thyroid Hormones and Cardiovascular Function and Diseases
  55. Older patients’ experience of primary hypothyroidism: A qualitative study
  56. Attitudes and perceptions of health professionals towards management of hypothyroidism in general practice: a qualitative interview study
  57. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism
  58. Diagnosis and Treatment of Hypothyroidism
  59. The role of local thyroid hormone perturbation in hippocampal sclerosis dementia—commentary on a multi-modality study
  60. Prevalence of treated hypothyroidism in the community: Analysis from general practices in North-East England with implications for the United Kingdom
  61. Patients’ attitudes and perceptions towards treatment of hypothyroidism in general practice: an in-depth qualitative interview study
  62. Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism—protocol for a systematic review
  63. Diagnosis and Treatment of Hypothyroidism
  64. Thyroid hormones and cardiovascular disease
  65. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
  66. Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis
  67. Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) – results from the feasibility randomised controlled trial
  68. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study
  69. Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease
  70. The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds
  71. Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study
  72. Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis
  73. Thyroid Function Within the Normal Range and Risk of Coronary Heart Disease
  74. Levothyroxine Improves Abnormal Cardiac Bioenergetics in Subclinical Hypothyroidism: A Cardiac Magnetic Resonance Spectroscopic Study
  75. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial
  76. Thyroid disease and vascular risk
  77. Thyroid Antibody Status, Subclinical Hypothyroidism, and the Risk of Coronary Heart Disease: An Individual Participant Data Analysis
  78. Blood Thrombogenicity Is Independently Associated With Serum TSH Levels in Post–Non-ST Elevation Acute Coronary Syndrome
  79. Reply on the Letter by Stott et al. ‘The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good'
  80. A Review of the Clinical Consequences of Variation in Thyroid Function Within the Reference Range
  81. Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED): protocol for a mixed methods feasibility study to assess the clinical utility of lower dose thyroxine in elderly hypothyroid patients: study protocol for a randomized controlled trial
  82. 2013 ETA Guideline: Management of Subclinical Hypothyroidism
  83. Thyroid and Aging or the Aging Thyroid? An Evidence-Based Analysis of the Literature
  84. Subclinical Hypothyroidism and Cardiovascular Disease—Reply
  85. Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality
  86. Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity
  87. Iodine status of UK schoolgirls: a cross-sectional survey
  88. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
  89. Subclinical thyroid disorders: significance and clinical impact
  90. The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort
  91. Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy
  92. Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
  93. Circulating endothelial progenitor cells, endothelial function, carotid intima–media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria
  94. Diagnosis and treatment of primary hypothyroidism
  95. The Influence of Age on the Relationship between Subclinical Hypothyroidism and Ischemic Heart Disease: A Metaanalysis
  96. Evaluation of New Measures of the Impact of Hypothyroidism on Quality of Life and Symptoms: The ThyDQoL and ThySRQ
  97. Do antithyroid drugs influence outcome after radioiodine therapy for hyperthyroidism?
  98. The Beneficial Effect ofl-Thyroxine on Cardiovascular Risk Factors, Endothelial Function, and Quality of Life in Subclinical Hypothyroidism: Randomized, Crossover Trial
  99. A 52-Year-Old Female with a Hoarse Voice and Tingling in the Hand
  100. Control of Hyperglycaemia in Intensive Care: How Much Control for how Much Benefit?
  101. What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves’ disease
  102. Psychometric Evaluation of a New Questionnaire Measuring Treatment Satisfaction in Hypothyroidism: The ThyTSQ
  103. Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review
  104. Health status in patients with sub-clinical hypothyroidism
  105. The detrimental effect of anti-thyroid drugs on the outcome of radioiodine therapy is not directly due to decreased radioiodine uptake
  106. Dose of Anti-thyroid Drugs can Effect Remission in Grave's Disease.
  107. Foot trauma due to foreign bodies — out of sight, out of mind?
  108. Design of New Questionnaires to Measure Quality of Life and Treatment Satisfaction in Hypothyroidism
  109. Subclinical Hypothyroidism and Cardiovascular Risk
  110. Subclinical Hypothyroidism and Cardiovascular Risk; Authors' Response; Combined T4 and T3 Therapy
  111. Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol
  112. Screening for diabetic retinopathy: a cause for concern in people who drive